This cross-sectional analysis used de-identified electronic health record data from the University of California Health Data Warehouse (UCHDW)/University of California Data Discovery Platform (UCDDP). The UCHDW integrates records from all six UC academic medical centers (Davis, Irvine, Los Angeles, Riverside, San Diego, and San Francisco). The study period spanned 2012 through March 2026. Per UC policy, studies using de-identified/limited data sets do not require separate institutional review board approval; the authors report compliance with relevant ethical guidelines. The report is a preprint and has not been peer reviewed.
Among individuals aged 1 year and older captured in the UC Health system during the study window, the investigators identified 713 patients with a clinical diagnosis of neurocysticercosis (NCC). This corresponded to an estimated prevalence of 6.17 per 100,000 within the UC Health population over the study period. A comparison cohort was selected at a 1:10 ratio to NCC cases for comparative analyses.
Compared with the randomly selected comparison group, patients with NCC were significantly older. The NCC cohort had a higher proportion of individuals identifying as Hispanic or Latino, and a greater frequency of Spanish as a primary language. Insurance status also differed: NCC patients were more likely to be insured through Medicaid. The authors highlight these findings as indicative that NCC in this setting disproportionately affects populations likely to face socioeconomic and structural barriers to care, including language barriers and immigration-related challenges.
In addition to the strong relationship with seizures and epilepsy, the study found that NCC was associated with a broader spectrum of neurologic and psychiatric conditions recorded in the medical records. Specifically, NCC showed associations with migraines, cognitive impairment, mood disorders, Parkinson’s disease, substance use, stroke, and sleep disorders. These associations were identified through comparison with the matched control sample drawn from the same data repository.
The analysis demonstrated a robust association between NCC and epilepsy. The reported odds ratio for epilepsy among NCC patients was 19.20 (95% CI 15.74–23.46), indicating markedly higher odds of documented epilepsy diagnoses compared with the comparison group. In adjusted models that controlled for age, gender, and ethnicity, male NCC patients had 26% higher odds of epilepsy than female NCC patients. The preprint provides these point estimates and confidence intervals as derived from the study data.
The authors conclude that NCC, while historically considered a disease of endemic regions, is being diagnosed within California health systems and contributes substantially to neurologic morbidity—especially epilepsy—in vulnerable patient populations. The findings underscore the need for clinicians in non-endemic settings to recognize NCC as a potential cause of seizures and other neuropsychiatric presentations, particularly among patients with limited English proficiency, Medicaid coverage, or connections to immigrant communities.
Limitations noted by the study design and data source include dependence on diagnostic coding within electronic health records and the use of a de-identified HIPAA limited data set; because the report is a preprint, it has not undergone peer review. The data are not publicly available due to privacy restrictions, although minimal de-identified aggregate tables may be available from the corresponding author upon request and subject to institutional approval. The authors indicate that the code used for analyses will be made publicly available upon publication of the article.
The UC Health Data Warehouse identified 713 NCC cases from 2012 to March 2026, yielding a prevalence estimate of 6.17 per 100,000 within the UC patient population.
Neurocysticercosis was strongly associated with epilepsy (OR 19.20, 95% CI 15.74–23.46) and with a range of other neuropsychiatric comorbidities.
NCC patients in this cohort were more likely to be older, identify as Hispanic or Latino, list Spanish as their primary language, and have Medicaid insurance, suggesting disproportionate impact on socioeconomically vulnerable groups.
Male NCC patients had 26% higher adjusted odds of epilepsy compared with female patients according to the study's adjusted analyses.
The study used de-identified EHR data across six academic centers; findings are reported in a preprint and should be interpreted in that context.